Market Blog » The Arora Report Stock Market News

MORE ON XENOPORT (XNPT)

April 8, 2011

The drug from Xenoport (XNPT) is for moderate to severe Restless Leg Syndrome. This drug will compete with existing treatments IT is not clear if the drug presents an advantage compared to the existing treatments with the exception of a small number of patients. It does not appear that the drug can generate enough profits to justify the jump in the stock price. For more details, see ZYX SHORT SELL CHANGE ALERTS www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade

XENOPORT (XNPT) IRRATIONAL EXUBERANCE ON HORIZANT.

April 8, 2011

Investors bid up shares of Xenoport (XNPT) by 56% on approval of Horizant.The company will have difficulty generating profits to support this huge stock move. We are now short from $10.18. For more details of the rationale to short sell, target tzone, stop zone,and real time updates, check out ZYX SHORT SELL CHANGE ALERTS. www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average

CUBIST PHARMACEUTICALS (CBST) ACQUISITION TARGET

April 5, 2011

Yesterday Cubist (CBST) settled its long running dispute with Teva Pharmaceuticals (TEVA). It appears that this development sets Cubist up to be acquired by a larger player. Cubist has received upgrades from several brokers. At present, cubist satisfies only three screens of the ZYX Change Method. We will issue an actionable signal in ZYX BUY CHANGE ALERTS when all six screens are meet. www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning

TEXAS INSTRUMENTS (TXN) TO BUY NATIONAL SEMICONDUCTOR (NSM)

April 4, 2011

Texas Instruments (TXN) has announced that it will buy National Semiconductor (NSM) for $25 a share. National Semiconductor closed at $14.07. Texas Instruments is paying a large premium. We do not expect a higher offer for National Semiconductor. We will issue an actionable signal to subscribers of ZYX BUY CHANGE ALERTS and ZYX SHORT SELL CHANGE ALERTS in real time when all six screens of the ZYX Change Method are satisfied. www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since

SOUTHWEST AIRLINES (LUV) ACCIDENT OFFERS OPPORTUNITY

April 4, 2011

The research at The Arora Report shows that airline accidents are always a buying opportunity. The Southwest Airlines (LUV) accident is no different. The stock is lower today, but it is not yet time to buy. At present, only three screens of the ZYX Change Method are positive. When and if all six screens turn positive, an actionable signal will be issued in the ZYX BUY CHANGE ALERTS. Along with the buy signal, stop zones and target zones will be provided. Further, ZYX BUY CHANGE ALERTS follows every trade from cradle to grave. Any buy price will be lower than $12.00. www.thearorareport.com THE ARORA

OMNIVISION (OVTI) LOWER ON SONY (SNE) RUMOR

April 4, 2011

Omnivision (OVTI) is falling out of bed. Omnivision has traditionally supplied all cameras to Apple (AAPL). President of Sony (SNE) hinted in an interview that Sony is working on supplying cameras to Apple. This interview accounts for today’s drop. Prior to the earnings the stock had also dropped on the same rumor, but then recovered and made new highs. In ZYX BUY CHANGE ALERTS we are holding Omnivision long from a price of $12.50. Any action needed will be provided in real real time in ZYX BUY CHANGE ALERTS . The subscribers receive changes in stop zones in addition to the buy

NVIDIA (NVDA) GETS ANOTHER DOWNGRADE

April 4, 2011

UBS lowered Nvidia (NVDA) estimates citing GPU weakness and aggressive marketing by Intel (INTC). UBS has lowered Nvidia price target lowered to $20. ZYX Change Method Quantitative Analysis screen still shows fair value of Nvidia to be $18. However, over 18, the stock is in weak hands. We have no position at present in Nvidia. All six screes of the ZYX Change Method do not support at this point unless the stock breaks down or bounces. We will issue an actionable signal in ZYX BUY CHANGE ALERTS and ZYX SHORT SELL CHANGE ALERTS, as appropriate, in real time when all six

LUNA INNOVATIONS (LUNA) IN NO-MAN’S-LAND

March 31, 2011

Luna Innovations (LUNA) is surging today after it entered into a multi year agreement with Intuitive Surgical (ISRG) to supply shape sensing systems for medical robotics. The news was expected. In general the news that is expected is already discounted in a stock price. However, sometimes in small caps such as Luna Innovations, either the news is not in the stock price or investors simply get too excited. According to the ZYX Change Method it is too late to buy and too early to short Luna Innovations. When the time is right we will issue an alert in ZYX BUY